Moroctocog alfa (trade name ReFacto) blood clotting factor VIII concentrate, used to treat haemophilia. The concentrated preparation is reconstituted
Moroctocog alfa (trade name ReFacto) blood clotting factor VIII concentrate, used to treat haemophilia. The concentrated preparation is reconstituted before intravenous injection. Haemophilia is a hereditary disorder in which the blood clots very slowly, due to a deficiency in one of the blood coagulation factors. Factor VIII, also known as anti-haemophilic factor (AHF), is an essential blood clotting agent in humans.
Size: 4961px × 3543px
Photo credit: © DR P. MARAZZI/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No
Keywords: -, -life, 8, 500, agent, ahf, alfa, anti-haemophilic, antihaemophilic, background, biotechnology, blood, body, box, boxed, chinese, cho, clotting, coagulation, concentrate, cut, cut-, cut-outs, cutout, cutouts, drug, drugs, engineered, engineering, factor, fviii, genetic, genetically, gm, gmo, haematological, haematology, haemophilia, haemophiliac, hamster, healthcare, hematology, hemophilia, hemophiliac, human, injection, intravenous, iu, iv, life, medical, medication, medicine, modification, moroctocog, outs, ovary, pack, packaging, packet, pharmaceutical, pharmaceuticals, pharmaceutics, pharmacological, pharmacology, powder, prescription, product, recombinant, reconstitution, refacto, shot, studio, therapy, treatment, viii, warning, white
